These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21572332)

  • 1. Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population.
    Singh AK; Pandey A; Tewari M; Shukla HS; Pandey HP
    Eur J Cancer Prev; 2011 Nov; 20(6):478-83. PubMed ID: 21572332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
    Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
    Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
    Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
    Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
    Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue.
    Bhavani V; Srinivasulu M; Ahuja YR; Hasan Q
    Cancer Biomark; 2009; 5(4):207-13. PubMed ID: 19729830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
    Kontorovich T; Cohen Y; Nir U; Friedman E
    Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.
    Iwamoto T; Yamamoto N; Taguchi T; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 129(1):69-77. PubMed ID: 20882403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients.
    Ben Gacem R; Hachana M; Ziadi S; Amara K; Ksia F; Mokni M; Trimeche M
    Cancer Epidemiol; 2012 Apr; 36(2):190-7. PubMed ID: 21978880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
    Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
    Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplo-insufficiency of BRCA1 in sporadic breast cancer.
    Staff S; Isola J; Tanner M
    Cancer Res; 2003 Aug; 63(16):4978-83. PubMed ID: 12941823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker.
    Jing F; Jun L; Yong Z; Wang Y; Fei X; Zhang J; Hu L
    Oncology; 2008; 75(1-2):60-6. PubMed ID: 18784433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the BRCA1 gene in sporadic breast cancer.
    Dobrovic A; Simpfendorfer D
    Cancer Res; 1997 Aug; 57(16):3347-50. PubMed ID: 9269993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk.
    Bean GR; Ibarra Drendall C; Goldenberg VK; Baker JC; Troch MM; Paisie C; Wilke LG; Yee L; Marcom PK; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Scott V; Seewaldt VL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):50-6. PubMed ID: 17220331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
    Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
    Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood DNA methylation detected in the BRCA1 or BRCA2 promoter for sporadic ovarian cancer patients and controls.
    Bosviel R; Michard E; Lavediaux G; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Clin Chim Acta; 2011 Jul; 412(15-16):1472-5. PubMed ID: 21557934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different methylation and microRNA expression pattern in male and female familial breast cancer.
    Pinto R; Pilato B; Ottini L; Lambo R; Simone G; Paradiso A; Tommasi S
    J Cell Physiol; 2013 Jun; 228(6):1264-9. PubMed ID: 23160909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
    Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
    Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.